| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1999;118:354-360
© 1999 Mosby, Inc.
CARDIOPULMONARY SUPPORT AND PHYSIOLOGY |
From the Divisions of Cardiovascular Surgerya and Hematology,b Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Address for reprints: Osamu Shigeta, MD, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, 305, Japan.
Objective: The heparin-protamine titration method that uses the Hepcon hemostasis management system (Medtronic HemoTec Inc, Englewood, Colo) reduced blood loss in cardiac surgery in previous reports, but the mechanism is not fully understood. This study tests the hypothesis that reduced protamine administration preserves platelet function in human cardiac surgery.
Methods: Platelet count, 
-granule secretion, and aggregation to thrombin before and after cardiopulmonary bypass in human beings were evaluated. In the control group (n = 14), a fixed dose of protamine (3 mg/kg) was administered. In the titration group (n = 20), protamine doses were based on the heparin concentration measured by the Hepcon system.
Results: Heparin concentrations before protamine administration were higher in the titration group (P = .0012), but protamine doses of patients in the titration group were markedly lower than those of the control group (P < .0001). During protamine infusion at a rate of 0.3 mg · kg–1 · min–1, the percentage of granule membrane protein-140–positive platelets significantly increased in the control group compared with the titration group (18.8% ± 8.6% vs 13.0% ± 5.3%, P = .0188). After protamine administration, aggregation of washed platelets to thrombin recovered almost to the preoperative level in the titration group; however, it remained lower in the control group (20% ± 20% vs 55% ± 18%, P = .0009).
Conclusion: Low-dose administration of protamine, based on a heparin-protamine titration method, restores not only the blood coagulation but also the platelet responses to thrombin and attenuates platelet -granule secretion during heparin neutralization. Overdose of protamine activates platelets and may predispose patients to excessive bleeding after cardiac surgery.
This article has been cited by other articles:
|
|
 |
|
  J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh, U. Lockowandt, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 73 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. B. Mossad, S. Machado, and J. Apostolakis Bleeding following deep hypothermia and circulatory arrest in children. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 34 - 46. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Federico, F. Annalisa, C. Giuseppe, D. S. Francesco, T. Lucia, and Z. Alberto Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration Perfusion, September 1, 2006; 21(5): 285 - 290. [Abstract] [PDF]
|
|
|
|
 |
|
 K. A. A. Aziz, O. Masood, J. A. Hoschtitzky, and A. Ronald Does use of the Hepcon(R) point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 469 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schneider, T. Sakert, J. Lucke, P. McKeown, and A. Sharma Cardiopulmonary bypass for a coronary artery bypass graft patient with heterozygous protein C deficiency and protein S deficiency Perfusion, March 1, 2006; 21(2): 117 - 120. [Abstract] [PDF]
|
|
|
|
|
|
R. Julian, J. J. Valdunciel, J. A. Sastre, and C. Muriel Aspirin-like defect in platelet secretion on a patient undergoing cardiac valve and coronary graft surgery. Perioperative management Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 153 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Oliver Jr Overview of Heparin and Protamine Management and Dosing Regimens in Pediatric Cardiac Surgical Patients Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2003; 7(4): 387 - 410. [Abstract] [PDF]
|
|
|
|
|
|
P D Raymond, M J Ray, S N Callen, and N A Marsh Heparin monitoring during cardiac surgery. Part 2: calculating the overestimation of heparin by the activated clotting time Perfusion, September 1, 2003; 18(5): 277 - 281. [Abstract] [PDF]
|
|
|
|
|
|
F. D. Rubens and T. Mesana Surface Modified Cardiopulmonary Bypass Circuits: Modifying the Inflammatory Response Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2002; 6(4): 301 - 306. [Abstract] [PDF]
|
|
|
|
|
|
C. Baufreton, J. L. de Brux, P. Binuani, J.-J. Corbeau, J. B. Subayi, J. C. Daniel, and P. Treanor A combined approach for improving cardiopulmonary bypass in coronary artery surgery: a pilot study Perfusion, December 1, 2002; 17(6): 407 - 413. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. Griffin, H. M. Rinder, B. R. Smith, J. B. Tracey, N. S. Kriz, C. K. Li, and C. S. Rinder The Effects of Heparin, Protamine, and Heparin/Protamine Reversal on Platelet Function Under Conditions of Arterial Shear Stress Anesth. Analg., July 1, 2001; 93(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hansen, A. Koster, M. Kukucka, F. Mertzlufft, and H. Kuppe A Quick Anti-Xa-Activity-Based Whole Blood Coagulation Assay for Monitoring Unfractionated Heparin During Cardiopulmonary Bypass: A Pilot Investigation Anesth. Analg., September 1, 2000; 91(3): 533 - 538. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
